Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States.

Allen MA, Liang TS, La Salvia T, Tjugum B, Gulakowski RJ, Murguía M.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):617-24.

PMID:
16284540
2.

Isolation and characterization of adociavirin, a novel HIV-inhibitory protein from the sponge Adocia sp.

O'Keefe BR, Erim T, Beutler JA, Cardellina JH 2nd, Gulakowski RJ, Krepps BL, McMahon JB, Sowder RC 2nd, Johnson DG, Buckheit RW Jr, Halliday S, Boyd MR.

FEBS Lett. 1998 Jul 10;431(1):85-90.

3.

Construction and enhanced cytotoxicity of a [cyanovirin-N]-[Pseudomonas exotoxin] conjugate against human immunodeficiency virus-infected cells.

Mori T, Shoemaker RH, McMahon JB, Gulakowski RJ, Gustafson KR, Boyd MR.

Biochem Biophys Res Commun. 1997 Oct 29;239(3):884-8.

PMID:
9367864
4.

Analysis of sequence requirements for biological activity of cyanovirin-N, a potent HIV (human immunodeficiency virus)-inactivating protein.

Mori T, Shoemaker RH, Gulakowski RJ, Krepps BL, McMahon JB, Gustafson KR, Pannell LK, Boyd MR.

Biochem Biophys Res Commun. 1997 Sep 8;238(1):218-22.

PMID:
9299482
5.

Michellamines D-F, new HIV-inhibitory dimeric naphthylisoquinoline alkaloids, and korupensamine E, a new antimalarial monomer, from Ancistrocladus korupensis.

Hallock YF, Manfredi KP, Dai JR, Cardellina JH 2nd, Gulakowski RJ, McMahon JB, Schäffer M, Stahl M, Gulden KP, Bringmann G, François G, Boyd MR.

J Nat Prod. 1997 Jul;60(7):677-83.

PMID:
9249970
6.

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

Boyd MR, Gustafson KR, McMahon JB, Shoemaker RH, O'Keefe BR, Mori T, Gulakowski RJ, Wu L, Rivera MI, Laurencot CM, Currens MJ, Cardellina JH 2nd, Buckheit RW Jr, Nara PL, Pannell LK, Sowder RC 2nd, Henderson LE.

Antimicrob Agents Chemother. 1997 Jul;41(7):1521-30.

7.

Isolation and characterization of niphatevirin, a human-immunodeficiency-virus-inhibitory glycoprotein from the marine sponge Niphates erecta.

O'Keefe BR, Beutler JA, Cardellina JH 2nd, Gulakowski RJ, Krepps BL, McMahon JB, Sowder RC 2nd, Henderson LE, Pannell LK, Pomponi SA, Boyd MR.

Eur J Biochem. 1997 Apr 1;245(1):47-53.

8.

Antireplicative and anticytopathic activities of prostratin, a non-tumor-promoting phorbol ester, against human immunodeficiency virus (HIV).

Gulakowski RJ, McMahon JB, Buckheit RW Jr, Gustafson KR, Boyd MR.

Antiviral Res. 1997 Jan;33(2):87-97.

PMID:
9021050
9.

Antiviral activity and mechanism of action of calanolide A against the human immunodeficiency virus type-1.

Currens MJ, Gulakowski RJ, Mariner JM, Moran RA, Buckheit RW Jr, Gustafson KR, McMahon JB, Boyd MR.

J Pharmacol Exp Ther. 1996 Nov;279(2):645-51.

PMID:
8930167
10.

Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B.

Galinis DL, Fuller RW, McKee TC, Cardellina JH 2nd, Gulakowski RJ, McMahon JB, Boyd MR.

J Med Chem. 1996 Oct 25;39(22):4507-10.

PMID:
8893846
11.

New pyranocoumarins isolated from Calophyllum lanigerum and Calophyllum teysmannii.

McKee TC, Fuller RW, Covington CD, Cardellina JH 2nd, Gulakowski RJ, Krepps BL, McMahon JB, Boyd MR.

J Nat Prod. 1996 Aug;59(8):754-8. Erratum in: J Nat Prod 1996 Nov;59(11):1108.

PMID:
8792623
12.

Biological and biochemical anti-human immunodeficiency virus activity of UC 38, a new non-nucleoside reverse transcriptase inhibitor.

McMahon JB, Buckheit RW Jr, Gulakowski RJ, Currens MJ, Vistica DT, Shoemaker RH, Stinson SF, Russell JD, Bader JP, Narayanan VL, Schultz RJ, Brouwer WG, Felauer EE, Boyd MR.

J Pharmacol Exp Ther. 1996 Jan;276(1):298-305.

PMID:
8558446
13.

Michellamine B, a novel plant alkaloid, inhibits human immunodeficiency virus-induced cell killing by at least two distinct mechanisms.

McMahon JB, Currens MJ, Gulakowski RJ, Buckheit RW Jr, Lackman-Smith C, Hallock YF, Boyd MR.

Antimicrob Agents Chemother. 1995 Feb;39(2):484-8.

14.

HIV-inhibitory natural products. 11. Comparative studies of sulfated sterols from marine invertebrates.

McKee TC, Cardellina JH 2nd, Riccio R, D'Auria MV, Iorizzi M, Minale L, Moran RA, Gulakowski RJ, McMahon JB, Buckheit RW Jr, et al.

J Med Chem. 1994 Mar 18;37(6):793-7.

PMID:
8145229
15.

Diarylsulfones, a new chemical class of nonnucleoside antiviral inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

McMahon JB, Gulakowski RJ, Weislow OS, Schultz RJ, Narayanan VL, Clanton DJ, Pedemonte R, Wassmundt FW, Buckheit RW Jr, Decker WD, et al.

Antimicrob Agents Chemother. 1993 Apr;37(4):754-60.

16.

A nonpromoting phorbol from the samoan medicinal plant Homalanthus nutans inhibits cell killing by HIV-1.

Gustafson KR, Cardellina JH 2nd, McMahon JB, Gulakowski RJ, Ishitoya J, Szallasi Z, Lewin NE, Blumberg PM, Weislow OS, Beutler JA, et al.

J Med Chem. 1992 May 29;35(11):1978-86.

PMID:
1597853
17.

A semiautomated multiparameter approach for anti-HIV drug screening.

Gulakowski RJ, McMahon JB, Staley PG, Moran RA, Boyd MR.

J Virol Methods. 1991 Jun;33(1-2):87-100.

PMID:
1719015
18.

Interactive laser cytometric analysis of retroviral protein expression in HIV-infected lymphocytic cell lines.

Warren JT, McMahon JB, Weislow OS, Gulakowski RJ, Kiser RF, Boyd MR.

AIDS Res Hum Retroviruses. 1990 Sep;6(9):1131-7.

PMID:
2265028

Supplemental Content

Loading ...
Support Center